John J. Barron

815 total citations
21 papers, 623 citations indexed

About

John J. Barron is a scholar working on Cardiology and Cardiovascular Medicine, Oncology and Economics and Econometrics. According to data from OpenAlex, John J. Barron has authored 21 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 7 papers in Oncology and 6 papers in Economics and Econometrics. Recurrent topics in John J. Barron's work include Economic and Financial Impacts of Cancer (5 papers), Global Cancer Incidence and Screening (3 papers) and Atrial Fibrillation Management and Outcomes (3 papers). John J. Barron is often cited by papers focused on Economic and Financial Impacts of Cancer (5 papers), Global Cancer Incidence and Screening (3 papers) and Atrial Fibrillation Management and Outcomes (3 papers). John J. Barron collaborates with scholars based in United States, Netherlands and Switzerland. John J. Barron's co-authors include James Spalding, A. W. Bakst, Hiangkiat Tan, Joseph Singer, Ralph Quimbo, Mayur M. Amonkar, Jay Margolis, Gosia Sylwestrzak, Rita F. Redberg and Alan Rosenberg and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

John J. Barron

19 papers receiving 604 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John J. Barron United States 12 197 172 132 117 107 21 623
Viktor Wintzell Sweden 15 198 1.0× 89 0.5× 61 0.5× 14 0.1× 44 0.4× 24 634
Jóhann P. Hreinsson Sweden 16 367 1.9× 420 2.4× 124 0.9× 7 0.1× 58 0.5× 63 762
Diane Eaton United Kingdom 5 134 0.7× 55 0.3× 566 4.3× 109 0.9× 57 0.5× 8 787
Lynne E. Lloyd United States 6 145 0.7× 100 0.6× 41 0.3× 33 0.3× 31 0.3× 6 703
Stephen Stemkowski United States 11 314 1.6× 15 0.1× 288 2.2× 25 0.2× 85 0.8× 25 587
R F Logan United Kingdom 16 891 4.5× 848 4.9× 108 0.8× 39 0.3× 56 0.5× 32 1.4k
Greta Lozano‐Ortega United States 13 88 0.4× 13 0.1× 93 0.7× 55 0.5× 25 0.2× 40 575
Jonathan Gribbin United Kingdom 10 108 0.5× 13 0.1× 91 0.7× 31 0.3× 115 1.1× 12 1.2k
Anne P. Ehlers United States 14 459 2.3× 104 0.6× 121 0.9× 20 0.2× 47 0.4× 79 708
Kristen Migliaccio–Walle United States 16 246 1.2× 7 0.0× 186 1.4× 205 1.8× 54 0.5× 48 856

Countries citing papers authored by John J. Barron

Since Specialization
Citations

This map shows the geographic impact of John J. Barron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John J. Barron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John J. Barron more than expected).

Fields of papers citing papers by John J. Barron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John J. Barron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John J. Barron. The network helps show where John J. Barron may publish in the future.

Co-authorship network of co-authors of John J. Barron

This figure shows the co-authorship network connecting the top 25 collaborators of John J. Barron. A scholar is included among the top collaborators of John J. Barron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John J. Barron. John J. Barron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barron, John J., Vincent J. Willey, Ozgur Tunceli, et al.. (2025). The Healthcare Integrated Research Database (HIRD) as a Real‐World Data Source for Pharmacoepidemiologic Research. Pharmacoepidemiology and Drug Safety. 34(2). e70110–e70110. 2 indexed citations
2.
Geynisman, Daniel M., Nathan R. Hill, Lisa Rosenblatt, et al.. (2025). Treatment Patterns and Costs Among Patients With Metastatic Renal Cell Carcinoma in the United States: A Real-World Study Using Integrated Claims and Clinical Data. JCO Oncology Practice. 21(11). 1609–1617.
3.
Gordon, Aliza S., et al.. (2023). The Association Between Mammography Screening Frequency and Breast Cancer Treatment and Outcomes: A Retrospective Cohort Study. Journal of Breast Imaging. 5(1). 21–29. 2 indexed citations
4.
Kanter, Genevieve P., Ravi B. Parikh, Michael Fisch, et al.. (2022). Trends in Medically Integrated Dispensing Among Oncology Practices. JCO Oncology Practice. 18(10). e1672–e1682. 5 indexed citations
5.
Gunturu, Krishna S., et al.. (2022). Immune checkpoint inhibitors: immune-related adverse events, healthcare utilization, and costs among commercial and Medicare Advantage patients. Supportive Care in Cancer. 30(5). 4019–4026. 17 indexed citations
6.
Parikh, Ravi B., Ezra Fishman, Robert P. Zimmerman, et al.. (2020). Association of Utilization Management Policy With Uptake of Hypofractionated Radiotherapy Among Patients With Early-Stage Breast Cancer. JAMA Oncology. 6(6). 839–839. 13 indexed citations
7.
Charlton, B., et al.. (2018). Length of hospitalization and mortality for bleeding during treatment with warfarin, dabigatran, or rivaroxaban. PLoS ONE. 13(3). e0193912–e0193912. 11 indexed citations
8.
Kern, David M., John J. Barron, Bingcao Wu, et al.. (2017). A validation of clinical data captured from a novel Cancer Care Quality Program directly integrated with administrative claims data. PubMed. Volume 8. 149–155. 13 indexed citations
9.
Sylwestrzak, Gosia, et al.. (2017). Major Bleeding Risk During Anticoagulation with Warfarin, Dabigatran, Apixaban, or Rivaroxaban in Patients with Nonvalvular Atrial Fibrillation. Journal of Managed Care & Specialty Pharmacy. 23(9). 968–978. 96 indexed citations
10.
Agiro, Abiy, Debra A. Patt, John J. Barron, et al.. (2016). Risk of Neutropenia-Related Hospitalization in Patients Who Received Colony-Stimulating Factors With Chemotherapy for Breast Cancer. Journal of Clinical Oncology. 34(32). 3872–3879. 18 indexed citations
11.
12.
Petersen, John L., John J. Barron, Bradley G. Hammill, et al.. (2010). Clopidogrel use and clinical events after drug-eluting stent implantation: Findings from the HealthCore Integrated Research Database. American Heart Journal. 159(3). 462–470.e1. 19 indexed citations
13.
Barron, John J., et al.. (2009). HER2 Testing and Subsequent Trastuzumab Treatment for Breast Cancer in a Managed Care Environment. The Oncologist. 14(8). 760–768. 26 indexed citations
14.
Barron, John J., et al.. (2007). Assessing the economic burden of breast cancer in a US managed care population. Breast Cancer Research and Treatment. 109(2). 367–377. 84 indexed citations
15.
Barron, John J., Hiangkiat Tan, James Spalding, A. W. Bakst, & Joseph Singer. (2007). Proton Pump Inhibitor Utilization Patterns in Infants. Journal of Pediatric Gastroenterology and Nutrition. 45(4). 421–427. 170 indexed citations
16.
Margolis, Jay, et al.. (2005). Health Care Resources and Costs for Treating Peripheral Artery Disease in a Managed Care Population: Results From Analysis of Administrative Claims Data. Journal of Managed Care Pharmacy. 11(9). 727–734. 59 indexed citations
17.
Barron, John J., et al.. (2004). Quality of Care and Attributable Healthcare Costs in Diabetic Hypertensive Patients Initiated on Calcium Antagonist Therapy. Clinical Drug Investigation. 24(11). 641–649.
18.
Al‐Zakwani, Ibrahim, et al.. (2003). Analysis of healthcare utilization patterns and adherence in patients receiving typical and atypical antipsychotic medications. Current Medical Research and Opinion. 19(7). 619–626. 40 indexed citations
19.
Martinꝉ, Roland, John J. Barron, & Christopher Zacker. (2001). Irritable bowel syndrome: toward a cost-effective management approach.. PubMed. 7(8 Suppl). S268–75. 40 indexed citations
20.
Wilson, Marcus D., et al.. (2000). Determination of ambulatory blood pressure control in treated patients with controlled office blood pressures. Blood Pressure Monitoring. 5(5). 263–269. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Viktor Wintzell Breakdown of academic impact, for papers by Jóhann P. Hreinsson Breakdown of academic impact, for papers by Diane Eaton Breakdown of academic impact, for papers by Lynne E. Lloyd Breakdown of academic impact, for papers by Stephen Stemkowski Breakdown of academic impact, for papers by R F Logan Breakdown of academic impact, for papers by Greta Lozano‐Ortega Breakdown of academic impact, for papers by Jonathan Gribbin Breakdown of academic impact, for papers by Anne P. Ehlers Breakdown of academic impact, for papers by Kristen Migliaccio–Walle
Rankless by CCL
2026